uric acid uptake (URAT1 transporter) inhibitor

approved as new uricosuric med. In JP

optimized to avoid mitochondrial toxicity

ACS Med. Chem. Lett., Jul. 20, 2020

Fuji Yakuhin, Saitama, JP

Structure of dotinurad, a novel selective urate reabsorption inhibitor

dotinurad (FYU-981) potently inhibits uric acid uptake by renal proximal tubule epithelial cells, increasing uric acid urinary secretion which can help hyperuricemic conditions like gout. The mechanism of action is…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: